Literature DB >> 17157298

Solution structure and NMR characterization of the binding to methylated histone tails of the plant homeodomain finger of the tumour suppressor ING4.

Alicia Palacios1, Pascal Garcia, Daniel Padró, Eva López-Hernández, Irene Martín, Francisco J Blanco.   

Abstract

Plant homeodomain (PHD) fingers are frequently present in proteins involved in chromatin remodelling, and some of them bind to histones. The family of proteins inhibitors of growth (ING) contains a PHD finger that bind to histone-3 trimethylated at lysine 4, and those of ING1 and ING2 also act as nuclear phosphoinositide receptors. We have determined the structure of ING4 PHD, and characterised its binding to phosphoinositides and histone methylated tails. In contrast to ING2, ING4 is not a phosphoinositide receptor and binds with similar affinity to the different methylation states of histone-3 at lysine 4.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17157298     DOI: 10.1016/j.febslet.2006.11.055

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  23 in total

Review 1.  Keeping it in the family: diverse histone recognition by conserved structural folds.

Authors:  Kyoko L Yap; Ming-Ming Zhou
Journal:  Crit Rev Biochem Mol Biol       Date:  2010-10-06       Impact factor: 8.250

2.  Plant homeodomain (PHD) fingers of CHD4 are histone H3-binding modules with preference for unmodified H3K4 and methylated H3K9.

Authors:  Robyn E Mansfield; Catherine A Musselman; Ann H Kwan; Samuel S Oliver; Adam L Garske; Foteini Davrazou; John M Denu; Tatiana G Kutateladze; Joel P Mackay
Journal:  J Biol Chem       Date:  2011-01-28       Impact factor: 5.157

Review 3.  The ING family tumor suppressors: from structure to function.

Authors:  Almass-Houd Aguissa-Touré; Ronald P C Wong; Gang Li
Journal:  Cell Mol Life Sci       Date:  2010-08-29       Impact factor: 9.261

4.  Crystallization and preliminary X-ray diffraction analysis of the dimerization domain of the tumour suppressor ING4.

Authors:  Simone Culurgioni; Inés G Muñoz; Alicia Palacios; Pilar Redondo; Francisco J Blanco; Guillermo Montoya
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2010-04-30

5.  A dominant mutant allele of the ING4 tumor suppressor found in human cancer cells exacerbates MYC-initiated mouse mammary tumorigenesis.

Authors:  Suwon Kim; Alana L Welm; J Michael Bishop
Journal:  Cancer Res       Date:  2010-05-25       Impact factor: 12.701

6.  Histone Deacetylase Inhibitor RGFP109 Overcomes Temozolomide Resistance by Blocking NF-κB-Dependent Transcription in Glioblastoma Cell Lines.

Authors:  Zong-Yang Li; Qing-Zhong Li; Lei Chen; Bao-Dong Chen; Bo Wang; Xie-Jun Zhang; Wei-Ping Li
Journal:  Neurochem Res       Date:  2016-09-08       Impact factor: 3.996

7.  Molecular basis of histone H3K4me3 recognition by ING4.

Authors:  Alicia Palacios; Inés G Muñoz; David Pantoja-Uceda; María J Marcaida; Daniel Torres; José M Martín-García; Irene Luque; Guillermo Montoya; Francisco J Blanco
Journal:  J Biol Chem       Date:  2008-04-01       Impact factor: 5.157

Review 8.  Structural insight into histone recognition by the ING PHD fingers.

Authors:  Karen S Champagne; Tatiana G Kutateladze
Journal:  Curr Drug Targets       Date:  2009-05       Impact factor: 3.465

9.  ING4 mediates crosstalk between histone H3 K4 trimethylation and H3 acetylation to attenuate cellular transformation.

Authors:  Tiffany Hung; Olivier Binda; Karen S Champagne; Alex J Kuo; Kyle Johnson; Howard Y Chang; Matthew D Simon; Tatiana G Kutateladze; Or Gozani
Journal:  Mol Cell       Date:  2009-01-30       Impact factor: 17.970

10.  Molecular architecture of quartet MOZ/MORF histone acetyltransferase complexes.

Authors:  Mukta Ullah; Nadine Pelletier; Lin Xiao; Song Ping Zhao; Kainan Wang; Cindy Degerny; Soroush Tahmasebi; Christelle Cayrou; Yannick Doyon; Siew-Lee Goh; Nathalie Champagne; Jacques Côté; Xiang-Jiao Yang
Journal:  Mol Cell Biol       Date:  2008-09-15       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.